Skip to content

Clinical trials

Phase 3 Primary Myelofibrosis trials in Sweden

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Primary Myelofibrosis Phase: Phase 3 Country / region: Sweden Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20101
20131
20161
20203
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie2
Novartis Pharmaceuticals2
Sierra Oncology LLC - a GSK company2
Celgene1
European Organisation for Research and Treatment of Cancer - EORTC1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Primary Myelofibrosis9
Neoplasms3
Anemia2
Blast Crisis1
Bone Marrow Diseases1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Embryonal1
Carcinoma, Ovarian Epithelial1
Dendritic Cell Sarcoma, Interdigitating1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.